Order Article Reprints

Fedele P, Rizzo A, Landriscina M, Stucci SL, Morritti M, Giuliani F, Moraca L, Cairo G, Ardito R, Giampaglia M, et al. Mutations and Efficacy of Pembrolizumab-Based Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer: A Real-World Multicenter Analysis. Journal of Clinical Medicine. 2025; 14(24):8854. https://doi.org/10.3390/jcm14248854

Fedele, Palma, Alessandro Rizzo, Matteo Landriscina, Stefania Luigia Stucci, Maria Morritti, Francesco Giuliani, Lucia Moraca, Giuseppe Cairo, Raffaele Ardito, Marianna Giampaglia, and et al. 2025. "Mutations and Efficacy of Pembrolizumab-Based Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer: A Real-World Multicenter Analysis" Journal of Clinical Medicine 14, no. 24: 8854. https://doi.org/10.3390/jcm14248854

Fedele, P., Rizzo, A., Landriscina, M., Stucci, S. L., Morritti, M., Giuliani, F., Moraca, L., Cairo, G., Ardito, R., Giampaglia, M., Bilancia, D., Melaccio, A., Terenzio, A., Gnoni, A., Licchetta, A., Fumai, F., Lanotte, L., & Gadaleta-Caldarola, G. (2025). Mutations and Efficacy of Pembrolizumab-Based Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer: A Real-World Multicenter Analysis. Journal of Clinical Medicine, 14(24), 8854. https://doi.org/10.3390/jcm14248854